New Jersey A 264: Permits patients to indicate that they should not be prescribed opiates and certain other controlled substances in prescription monitoring program information.

Status: Introduced in the Assembly, Referred to Assembly Health Committee (as of 2020-01-14)

State: New Jersey · Session: 219 · Bill: A 264

Subjects: DRUG ABUSE, PHARMACEUTIC

Sponsors: Armato, John, Mazzeo, Vincent

View New Jersey A 264 on LegisTrack → — full text, sponsors, votes, campaign finance, and cross-state matches.